Parenteral fish oil as a pharmacological agent to modulate post-operative immune response: a randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer.

@article{Torrinhas2013ParenteralFO,
  title={Parenteral fish oil as a pharmacological agent to modulate post-operative immune response: a randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer.},
  author={Raquel Susana Matos de Miranda Torrinhas and Raquel Ara{\'u}jo Santana and Thais Helena Bigliazzi Garcia and Maria Fernanda Cury-Boaventura and Maria Mirtes Sales and R. A. Curi and Dan Linetzky Waitzberg},
  journal={Clinical nutrition},
  year={2013},
  volume={32 4},
  pages={
          503-10
        }
}
BACKGROUND Fish oil-based lipid emulsions (FOLEs) have shown post-operative immunological and clinical benefits in parenteral nutrition. AIM To assess post-operative immune response after short-term pre-operative parenteral infusion of isolated FOLE in gastrointestinal cancer patients. METHODS The patients (n = 63) received pre-operative peripheral infusion (0.2 g fat/kg body weight/d) of FOLE (Omegaven(®)) or control lipid emulsion (MCT/LCT; Lipovenos MCT(®)) for 3 days. Post-operative… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS